Store-operated calcium entry dysfunction in CRAC channelopathy: Insights from a novel STIM1 mutation
Clinical Immunology · 2024-08 · 265 · 110306
DOI: 10.1016/j.clim.2024.110306 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Immunology, 2024-08. Verfasst von Benedicte Alary und 9 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, INSERM, MMG, U1251 Marseille, France. Hauptthemen laut MEDLINE: Stromal Interaction Molecule 1, Neoplasm Proteins, Mutation, Calcium. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Store-operated calcium entry (SOCE) plays a crucial role in maintaining cellular calcium homeostasis. This mechanism involves proteins, such as stromal interaction molecule 1 (STIM1) and ORAI1. Mutations in the genes encoding these proteins, especially STIM1, can lead to various diseases, including CRAC channelopathies associated with severe combined immunodeficiency. Herein, we describe a novel homozygous mutation, NM_003156 c.792-3C > G, in STIM1 in a patient with a clinical profile of CRAC channelopathy, including immune system deficiencies and muscle weakness. Functional analyses revealed three distinct spliced forms in the patient cells: wild-type, exon 7 skipping, and intronic retention. Calcium influx analysis revealed impaired SOCE in the patient cells, indicating a loss of STIM1 function. We developed an antisense oligonucleotide treatment that improves STIM1 splicing and highlighted its potential as a therapeutic approach. Our findings provide insights into the complex effects of STIM1 mutations and shed light on the multifaceted clinical presentation of the patient.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Aix Marseille Univ, INSERM, MMG, U1251 Marseille, France.
- Centre de Référence Maladies Rares Neuromusculaire, CHU Toulouse, Toulouse, France.
- Université Paris-Saclay, INSERM, U1193 Orsay, France.
- Laboratoire de Génétique Moléculaire, CHU Montpellier, Montpellier, France.
- Laboratoire de Génétique Moléculaire, CHU Montpellier, Montpellier, France; PhyMedExp (Physiologie et Médecine Expérimentale du Cœur et des Muscles), Université de Montpellier, Inserm U1046, CNRS UMR9214, Montpellier, F…
- Aix Marseille Univ, INSERM, MMG, U1251 Marseille, France; Département de Génétique Médicale, Hôpital Timone Enfants, APHM, Marseille, France.
Zitieren
APA
Alary, B., Cintas, P., Claude, C., Dellis, O., Thèze, C., Van Goethem, C., Cossée, M., Krahn, M., Delague, V., & Bartoli, M. (2024). Store-operated calcium entry dysfunction in CRAC channelopathy: Insights from a novel STIM1 mutation. Clinical Immunology, 265, 110306. https://doi.org/10.1016/j.clim.2024.110306
Vancouver
Alary B, Cintas P, Claude C, Dellis O, Thèze C, Van Goethem C, et al. Store-operated calcium entry dysfunction in CRAC channelopathy: Insights from a novel STIM1 mutation. Clinical Immunology. 2024;265:110306. doi:10.1016/j.clim.2024.110306
BibTeX
@article{Alary2024,
author = {Alary, Benedicte and Cintas, Pascal and Claude, Corentin and Dellis, Olivier and Thèze, Corinne and Van Goethem, Charles and Cossée, Mireille and Krahn, Martin and Delague, Valérie and Bartoli, Marc},
title = {Store-operated calcium entry dysfunction in CRAC channelopathy: Insights from a novel STIM1 mutation},
journal = {Clinical Immunology},
year = {2024},
volume = {265},
pages = {110306},
doi = {10.1016/j.clim.2024.110306}
}
EUVIMED